Heartflow Inc
HTFL31.605USD
+1.095+3.59%
Market hours （ET）Quotes delayed by 15 min
2.64BMarket Cap
LossP/E TTM
More Details of Heartflow Inc Company
HeartFlow Inc. is a commercial-stage medical technology company that has pioneered the use of software and artificial intelligence (AI) to deliver a non-invasive solution for diagnosing and managing coronary artery disease (CAD). The Company’s novel HeartFlow Platform uses AI and advanced computational fluid dynamics to create a personalized three-dimensional (3D) model of a patient’s heart based on a single coronary computed tomography angiography (CCTA). Its AI-driven platform includes Roadmap Analysis, FFRCT Analysis and Plaque Analysis. The HeartFlow FFRCT Analysis and Plaque Analysis software assists physicians in diagnosing, managing and delivering precision care to patients with CAD. The RoadMap Analysis offers a highly intuitive anatomic visualization of the coronary arteries, helping physicians quickly identify clinically relevant areas to focus their review.
Heartflow Inc Info
Ticker SymbolHTFL
Company nameHeartflow Inc
IPO dateAug 08, 2025
CEOFarquhar (John C. M)
Number of employees699
Security typeOrdinary Share
Fiscal year-endAug 08
Address331 E Evelyn Avenue
CityMOUNTAIN VIEW
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code94041
Phone16502411221
Websitehttps://www.heartflow.com/
Ticker SymbolHTFL
IPO dateAug 08, 2025
CEOFarquhar (John C. M)
Company Executives of Heartflow Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Vikram Verghese
Mr. Vikram Verghese
Chief Financial Officer
Chief Financial Officer
123.86K
-0.38%
Mr. Lonnie M. Smith
Mr. Lonnie M. Smith
Independent Director
Independent Director
34.25K
--
Mr. Casey M. Tansey
Mr. Casey M. Tansey
Independent Director
Independent Director
16.45K
--
Dr. Campbell D. Rogers, M.D.
Dr. Campbell D. Rogers, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Tim Barabe
Mr. Tim Barabe
Independent Director
Independent Director
--
--
Ms. Julie Cullivan
Ms. Julie Cullivan
Independent Director
Independent Director
--
--
Mr. Jeffrey C. Lightcap
Mr. Jeffrey C. Lightcap
Independent Director
Independent Director
--
--
Mr. William C. (Bill) Weldon
Mr. William C. (Bill) Weldon
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Wayne Riley, M.D.
Dr. Wayne Riley, M.D.
Independent Director
Independent Director
--
--
Dr. Nicholas Downing, M.D.
Dr. Nicholas Downing, M.D.
Director
Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Vikram Verghese
Mr. Vikram Verghese
Chief Financial Officer
Chief Financial Officer
123.86K
-0.38%
Mr. Lonnie M. Smith
Mr. Lonnie M. Smith
Independent Director
Independent Director
34.25K
--
Mr. Casey M. Tansey
Mr. Casey M. Tansey
Independent Director
Independent Director
16.45K
--
Dr. Campbell D. Rogers, M.D.
Dr. Campbell D. Rogers, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Tim Barabe
Mr. Tim Barabe
Independent Director
Independent Director
--
--
Ms. Julie Cullivan
Ms. Julie Cullivan
Independent Director
Independent Director
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Sun, Nov 30
Updated: Sun, Nov 30
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Bain Capital Life Sciences Investors, LLC
14.62%
HealthCor Partners Management LP
7.86%
Wellington Management Company, LLP
5.73%
Fidelity Management & Research Company LLC
5.42%
Capricorn Investment Group LLC
4.61%
Other
61.76%
Shareholders
Shareholders
Proportion
Bain Capital Life Sciences Investors, LLC
14.62%
HealthCor Partners Management LP
7.86%
Wellington Management Company, LLP
5.73%
Fidelity Management & Research Company LLC
5.42%
Capricorn Investment Group LLC
4.61%
Other
61.76%
Shareholder Types
Shareholders
Proportion
Investment Advisor
53.56%
Investment Advisor/Hedge Fund
12.32%
Hedge Fund
3.14%
Individual Investor
2.47%
Endowment Fund
0.37%
Private Equity
0.18%
Pension Fund
0.14%
Research Firm
0.10%
Bank and Trust
0.08%
Other
27.65%
Institutional Shareholding
Updated: Fri, Sep 12
Updated: Fri, Sep 12
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
46
45.42M
54.46%
+42.91M
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Bain Capital Life Sciences Investors, LLC
12.45M
14.93%
+12.45M
--
Aug 08, 2025
HealthCor Partners Management LP
6.70M
8.03%
+6.70M
--
Aug 08, 2025
Wellington Management Company, LLP
4.41M
5.29%
+4.41M
--
Aug 08, 2025
Fidelity Management & Research Company LLC
3.29M
3.94%
+3.29M
--
Aug 08, 2025
Capricorn Investment Group LLC
3.92M
4.7%
+3.92M
--
Aug 08, 2025
Hayfin Capital Management LLP
3.64M
4.36%
+3.64M
--
Aug 08, 2025
The Vanguard Group, Inc.
1.17M
1.4%
+1.17M
--
Aug 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
TrueShares Technology, AI & Deep Learning ETF
3.13%
Global X HealthTech ETF
1.75%
Fidelity Blue Chip Growth ETF
0.07%
T Rowe Price Small-Mid Cap ETF
0.06%
iShares Health Innovation Active ETF
0.02%
Schwab U.S. Small-Cap ETF
0.02%
Fidelity Nasdaq Composite Index ETF
0.01%
Schwab U.S. Broad Market ETF
0%
TrueShares Technology, AI & Deep Learning ETF
Proportion3.13%
Global X HealthTech ETF
Proportion1.75%
Fidelity Blue Chip Growth ETF
Proportion0.07%
T Rowe Price Small-Mid Cap ETF
Proportion0.06%
iShares Health Innovation Active ETF
Proportion0.02%
Schwab U.S. Small-Cap ETF
Proportion0.02%
Fidelity Nasdaq Composite Index ETF
Proportion0.01%
Schwab U.S. Broad Market ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Heartflow Inc?
The top five shareholders of Heartflow Inc are:
Bain Capital Life Sciences Investors, LLC holds 12.45M shares, accounting for 14.93% of the total shares.
HealthCor Partners Management LP holds 6.70M shares, accounting for 8.03% of the total shares.
Wellington Management Company, LLP holds 4.41M shares, accounting for 5.29% of the total shares.
Fidelity Management & Research Company LLC holds 3.29M shares, accounting for 3.94% of the total shares.
Capricorn Investment Group LLC holds 3.92M shares, accounting for 4.70% of the total shares.
Bain Capital Life Sciences Investors, LLC holds 12.45M shares, accounting for 14.93% of the total shares.
HealthCor Partners Management LP holds 6.70M shares, accounting for 8.03% of the total shares.
Wellington Management Company, LLP holds 4.41M shares, accounting for 5.29% of the total shares.
Fidelity Management & Research Company LLC holds 3.29M shares, accounting for 3.94% of the total shares.
Capricorn Investment Group LLC holds 3.92M shares, accounting for 4.70% of the total shares.
What are the top three shareholder types of Heartflow Inc?
The top three shareholder types of Heartflow Inc are:
Bain Capital Life Sciences Investors, LLC
HealthCor Partners Management LP
Wellington Management Company, LLP
Bain Capital Life Sciences Investors, LLC
HealthCor Partners Management LP
Wellington Management Company, LLP
How many institutions hold shares of Heartflow Inc (HTFL)?
As of 2025Q3, 46 institutions hold shares of Heartflow Inc, with a combined market value of approximately 45.42M, accounting for 54.46% of the total shares. Compared to --, institutional shareholding has increased by --.
What is the biggest source of revenue for Heartflow Inc?
In --, the -- business generated the highest revenue for Heartflow Inc, amounting to -- and accounting for --% of total revenue.
